Insider Trades
News
businesswire.comVir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directorsbusinesswire.comJun 10
businesswire.comVir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026businesswire.comMay 18
fool.comVir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Millionfool.comMay 18
fool.comVir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Sharesfool.comMay 17
seekingalpha.comVir Biotechnology: Trading Near Cash Value With A Huge Revenue Opportunityseekingalpha.comMay 16